New Works by Robert Deyber, Excusively at Martin Lawrence

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
117
New Works by Robert Deyber, Excusively at Martin Lawrence Galleries

San Francisco, California, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Martin Lawrence Galleries (MLG) Geary Street has been the heart and soul of San Francisco’s fine art district for decades. The gallery, at 366 Geary St., is one of nine world class locations that comprise Martin Lawrence Galleries, the nation's preeminent network of fine art galleries, showcasing masters of the 20th and 21st century. Today MLG Geary St. proudly announced it is presenting brand new works from renowned contemporary artist, Robert Deyber.    Please join MLG on Saturday, November 18th for the unveiling of never-before-seen original paintings and limited edition works of art by Deyber, and get the chance to meet this uniquely talented artist in person.   Robert Deyber is a visual raconteur who uses his paintbrush to bring familiar verbal expressions to canvas in a most clever way. His original works are coveted by thousands of collectors across the country and around the globe. Deyber was originally inspired by a devotion to Surrealist geniuses René Magritte and Salvador Dalí, as well as 15th Century Rebus Art Form. The rebus form, a device that utilizes pictures to represent words or part of words, is essentially a picto-language that has held sway over historical cultures including as the ancient Egyptians, Chinese and Europeans.   Deyber's ‘phrases as images’ move the viewer in and out of visual themes and storylines; his colors and light are often contrasted against the landscape and scenery of the legendary artist’s surroundings. Deyber delights in creating amusing visual homages to nature, animals and his sub-conscious.   “I consider each painting a story, with a beginning, middle and an end. Their have been paintings which have been in the beginning stages for three years. This same is true with the middle stage. Eventually, each painting presents itself and draws to a logical conclusion”-Robert Deyber.   Robert Deyber was born and raised in Greenwich, Connecticut and has sketched and painted since his teen years. Martin Lawrence Galleries is the exclusive representative of Deyber works, and offers both unique paintings and original limited-edition prints in each of its nine world class galleries across the country.    Please RSVP for your opportunity to meet Robert Deyber on November 18th, or stop by the gallery at 366 Geary Street. RSVP (415) 956-0345, or visit at  geary@martinlawrence.com  

About Martin Lawrence Galleries

 

Since 1975, Martin Lawrence Galleries (MLG), headquartered in Greenwich, Connecticut with nine galleries nationwide including New York, Chicago, Dallas, Las Vegas, New Orleans, San Francisco, Costa Mesa, La Jolla, Maui and online at martinlawrence.com, has assisted and advised collectors in acquiring fine art. (MLG), with its unparalleled collection of treasures, specializes in unique paintings and limited-edition graphics and sculpture by Warhol, Haring, Murakami, Chagall, Picasso and Erté. Over the last 15 years, it has lent nearly 250 artworks by 16 different artists to 32 museums around the world, and proudly publishes works by artists including Kondakova, Hallam, Bertho, Fressinier, Lalonde and Deyber. For more information visit www.martinlawrence.com.

Follow Martin Lawrence Galleries on Twitter (@TwitterMLG), Facebook (@martinlawrencegalleries) and Instagram (@martinlawrencegalleries). 

For more Information or an interview and/or gallery tour, contact Katia Graytok: 203.989.2073 kgraytok@martinlawrence.com NOTE: High-resolution images of all artists work represented by Martin Lawrence galleries are available upon request.

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...a5877edf8d

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...b49c61b988

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...55adf7e174

Katia Graytok Martin Lawrence Galleries (203)989-2073 kgraytok@martinlawrence.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

You Call The Play Inc. (YCTP) Leads with Integrity in Betting

Updated Category News Views 154

Understanding You Call The Play Inc. (YCTP)'s Initiative In an important move for the sports betting landscape, You Call The Play Inc. (YCTP) has recently unveiled a national licensing plan and a groundbreaking measure called the Safe Bet Overlay™. This initiative is designed to foster trust and transparency within an industry that continues to grow rapidly across the...

Continue Reading
Cash for Houses Pro Earns Stellar Reputation with 5-Star Reviews

Updated Category News Views 167

Cash for Houses Pro Achieves 5-Star Reviews Cash for Houses Pro is celebrating their recent success in receiving numerous 5-star reviews on Google for their service known as 'Sell Your House Fast In Tampa FL For Cash'. This recognition reflects the team's dedication to providing homeowners with a seamless and stress-free home selling experience. About Cash for Houses Pro...

Continue Reading
Pfizer's Potential Transformation Following Starboard Investment

Updated Category News Views 77

Pfizer's Revised Price Target and Market Standing Recently, CFRA, a prominent financial research firm, elevated its price target for Pfizer Inc. (NYSE:PFE) from $30.00 to $31.00 per share. This adjustment comes while maintaining a 'Hold' rating on the stock, suggesting a careful observation of its market performance. The current price target reflects a valuation based on...

Continue Reading
Equinox Gold's Impressive Q2 Results Spark Stock Surge Today

Updated Category News Views 103

Equinox Gold Delivers Strong Quarterly Performance Equinox Gold Corp. EQX has seen its shares rise significantly following the release of its second-quarter financial results, which exceeded market expectations. Investors reacted favorably, driving the stock up on Thursday. Financial Highlights from the Quarter In the latest quarterly report, Equinox Gold announced...

Continue Reading
Investor Insights on Alexandria Real Estate Equities' Legal Challenges

Updated Category News Views 219

Understanding the Alexandria Real Estate Equities, Inc. Lawsuit Investors have an important opportunity arising from a lawsuit against Alexandria Real Estate Equities, Inc. (NYSE: ARE). A national shareholder rights litigation firm has initiated a class action alleging the Company has violated various securities laws. This situation has caught the attention of many...

Continue Reading